ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
Royalsandman
|
5.5K |
2.7M |
3 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
5.5K
|
2.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
Royalsandman
|
905 |
287K |
4 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
905
|
287K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
The Psychology of Trading
|
|
Royalsandman
|
905 |
287K |
7 |
08/06/22 |
08/06/22 |
ASX - By Stock
|
905
|
287K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
Royalsandman
|
905 |
291K |
8 |
03/06/22 |
03/06/22 |
ASX - By Stock
|
905
|
291K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
CLBP
|
|
Royalsandman
|
119 |
26K |
10 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
119
|
26K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Royalsandman
|
17K |
6.8M |
47 |
16/05/22 |
16/05/22 |
ASX - By Stock
|
17K
|
6.8M
|
47
|
|
ASX - By Stock
|
MSB |
Re:
oh! Going Great
|
|
Royalsandman
|
63 |
34K |
12 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
63
|
34K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Royalsandman
|
17K |
6.8M |
17 |
28/04/22 |
28/04/22 |
ASX - By Stock
|
17K
|
6.8M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Growing doubt on COVID-19 Application
|
|
Royalsandman
|
4.7K |
1.1M |
19 |
05/04/22 |
05/04/22 |
ASX - By Stock
|
4.7K
|
1.1M
|
19
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Royalsandman
|
1.0K |
331K |
11 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
1.0K
|
331K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Royalsandman
|
17K |
6.8M |
7 |
01/04/22 |
01/04/22 |
ASX - By Stock
|
17K
|
6.8M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
Royalsandman
|
505 |
161K |
7 |
17/03/22 |
17/03/22 |
ASX - By Stock
|
505
|
161K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
Royalsandman
|
778 |
283K |
2 |
13/03/22 |
13/03/22 |
ASX - By Stock
|
778
|
283K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
Royalsandman
|
778 |
283K |
12 |
13/03/22 |
13/03/22 |
ASX - By Stock
|
778
|
283K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
2022 ... Get your popcorn out!
|
|
Royalsandman
|
778 |
283K |
10 |
13/03/22 |
13/03/22 |
ASX - By Stock
|
778
|
283K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
Royalsandman
|
505 |
161K |
0 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
505
|
161K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
Royalsandman
|
505 |
161K |
6 |
11/03/22 |
11/03/22 |
ASX - By Stock
|
505
|
161K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
Royalsandman
|
505 |
161K |
6 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
505
|
161K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Short Squeeze
|
|
Royalsandman
|
505 |
161K |
22 |
10/03/22 |
10/03/22 |
ASX - By Stock
|
505
|
161K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
MSB - Maximum Market Size
|
|
Royalsandman
|
68 |
22K |
10 |
04/03/22 |
04/03/22 |
ASX - By Stock
|
68
|
22K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MESOBLAST- FUNDAMENTALS discussions
|
|
Royalsandman
|
305 |
115K |
5 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
305
|
115K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Q2 Financial Results and Operational Highlights
|
|
Royalsandman
|
219 |
56K |
4 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
219
|
56K
|
4
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Westpac announces $3.5 billion off-market share buy-back
|
|
Royalsandman
|
1K |
505K |
5 |
14/02/22 |
14/02/22 |
ASX - By Stock
|
1K
|
505K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
Royalsandman
|
905 |
291K |
10 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
905
|
291K
|
10
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Westpac announces $3.5 billion off-market share buy-back
|
|
Royalsandman
|
1K |
505K |
5 |
11/02/22 |
11/02/22 |
ASX - By Stock
|
1K
|
505K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
RWE for 2nd MSB COVID-19 ARDS P3 Trial
|
|
Royalsandman
|
905 |
291K |
9 |
10/02/22 |
10/02/22 |
ASX - By Stock
|
905
|
291K
|
9
|
|
ASX - By Stock
|
WBC |
Re:
Ann: Westpac announces $3.5 billion off-market share buy-back
|
|
Royalsandman
|
1K |
505K |
3 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
1K
|
505K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2022, The TurnAround
|
|
Royalsandman
|
1.0K |
331K |
20 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
1.0K
|
331K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Royalsandman
|
10K |
3.1M |
10 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
3.1M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Royalsandman
|
10K |
3.1M |
1 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
3.1M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Royalsandman
|
10K |
3.1M |
7 |
02/02/22 |
02/02/22 |
ASX - By Stock
|
10K
|
3.1M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Appendix 4C Quarterly Activity Report
|
|
Royalsandman
|
151 |
41K |
21 |
31/01/22 |
31/01/22 |
ASX - By Stock
|
151
|
41K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
CHF - MSB's Dark Horse with Multi-billion dollar potential
|
|
Royalsandman
|
516 |
157K |
40 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
516
|
157K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer Covid Pill: Gameover for MSB's treatment
|
|
Royalsandman
|
41 |
10K |
6 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
41
|
10K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Walking dead invade MSB offices
|
|
Royalsandman
|
35 |
8.2K |
50 |
28/01/22 |
28/01/22 |
ASX - By Stock
|
35
|
8.2K
|
50
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Royalsandman
|
880 |
215K |
7 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
215K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Royalsandman
|
880 |
215K |
11 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
215K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Silviu Itescu The Legend
|
|
Royalsandman
|
880 |
215K |
7 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
880
|
215K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Royalsandman
|
17K |
6.8M |
4 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
17K
|
6.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Royalsandman
|
17K |
6.8M |
37 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
17K
|
6.8M
|
37
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Royalsandman
|
17K |
6.8M |
3 |
07/01/22 |
07/01/22 |
ASX - By Stock
|
17K
|
6.8M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on FDA Meeting for Remestemcel-L in Paediatric GvHD
|
|
Royalsandman
|
211 |
73K |
44 |
31/12/21 |
31/12/21 |
ASX - By Stock
|
211
|
73K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
A Lesson from Osiris
|
|
Royalsandman
|
66 |
20K |
6 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
66
|
20K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
A Lesson from Osiris
|
|
Royalsandman
|
66 |
20K |
10 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
66
|
20K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
A Lesson from Osiris
|
|
Royalsandman
|
66 |
20K |
27 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
66
|
20K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
A Lesson from Osiris
|
|
Royalsandman
|
66 |
20K |
5 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
66
|
20K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
A Lesson from Osiris
|
|
Royalsandman
|
66 |
20K |
11 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
66
|
20K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
A Lesson from Osiris
|
|
Royalsandman
|
66 |
20K |
5 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
66
|
20K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
A Lesson from Osiris
|
|
Royalsandman
|
66 |
20K |
80 |
24/12/21 |
24/12/21 |
ASX - By Stock
|
66
|
20K
|
80
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Royalsandman
|
850 |
253K |
2 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
850
|
253K
|
2
|
|